close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Abpro Corporation

News headline image
Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers
From Abpro Corporation
Via GlobeNewswire
Tickers ABP
News headline image
Abpro Granted Nasdaq Listing Extension to Pursue Compliance and Strategic Objectives
From Abpro Corporation
Via GlobeNewswire
Tickers ABP
News headline image
Abpro and Celltrion to Present Preclinical Data for CT-P72/ABP-102 at SITC 2025, Highlighting a Next-Generation HER2×CD3 T-Cell Engager
From Abpro Corporation
Via GlobeNewswire
Tickers ABP
News headline image
Abpro Announces 1-for-30 Reverse Stock Split Effective November 3, 2025
From Abpro Corporation
Via GlobeNewswire
Tickers ABP
News headline image
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager
From Abpro Corporation
Via GlobeNewswire
Tickers ABP
News headline image
Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025
From Abpro Corporation
Via GlobeNewswire
Tickers ABP
News headline image
Abpro Statement on the Departure of Former CEO Ian Chan
From Abpro Corporation
Via GlobeNewswire
Tickers ABP
News headline image
Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing
From Abpro Corporation
Via GlobeNewswire
Tickers ABP
News headline image
Abpro Announces Filing of Registration Statement on Form S-4 in Connection with Business Combination Agreement with Atlantic Coastal Acquisition Corp. II
From Abpro Corporation
Via GlobeNewswire
Tickers ABP ACAB
News headline image
Abpro to Become Publicly Traded via Merger with Atlantic Coastal Acquisition Corp. II
From Abpro Corporation
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today